EUROPEAN HEART JOURNAL, cilt.31, sa.23, ss.2844-2855, 2010 (SCI-Expanded, Scopus)
The aims of the study were, first, to critically evaluate lipoprotein(a) [Lp(a)] as a cardiovascular risk factor and, second, to advise on screening for elevated plasma Lp(a), on desirable levels, and on therapeutic strategies.